	Lucro Bruto Sobre Vendas		Data
Abbott	USD 6.54B	625M	2025-12
Acadia Pharmaceuticals	USD 257.76M	778K	2025-12
Agios Pharmaceuticals	USD 18.09M	6.89M	2025-12
Akebia Therapeutics	USD 49.21M	13.25M	2025-03
Alnylam Pharmaceuticals	USD 829.31M	219.56M	2025-12
AstraZeneca	USD 12.39B	5M	2025-12
BioMarin Pharmaceutical	USD 713.01M	81.81M	2025-12
Coherus Biosciences	USD 4.95M	15.34M	2025-03
Eli Lilly	USD 14.59B	1.48B	2025-09
Esperion Therapeutics	USD -29.52M	32.4M	2024-09
Halozyme Therapeutics	USD 281.77M	2.41M	2025-09
Illumina	USD 759M	26M	2025-12
Insmed	USD 217.69M	106.25M	2025-12
Ironwood Pharmaceuticals	USD 85.24M	44.1M	2025-06
J&J	USD 16.6B	118M	2025-12
Lexicon Pharmaceuticals	USD -16.16M	2.89M	2024-06
MacroGenics	USD 61.25M	88.71M	2025-09
MannKind	USD 78.31M	76.21M	2025-12
Merck	USD 13.42B	431M	2025-09
Moderna	USD 226M	583M	2025-12
Novartis	USD 10.82B	695M	2025-09
PTC Therapeutics	USD 148.38M	39.31M	2025-12
Puma Biotechnology	USD 20.32M	24.85M	2024-09
Sarepta Therapeutics	USD 43.55M	204.36M	2025-12
Thermo Fisher Scientific	USD 4.64B	419M	2025-12
Ultragenyx Pharmaceutical	USD 178M	46.06M	2025-12
United Therapeutics	USD 315.5M	286.6M	2025-12
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12

Lexicon Pharmaceuticals Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.